Coronavirus: Indonesia approves Sinopharm vaccine for emergency use; Thailand says latest wave has peaked

Indonesia’s drug regulator on Friday approved the Covid-19 vaccine of China’s Sinopharm, which it will use in a private immunisation scheme where companies buy government-procured vaccines to inoculate their staff.After Sinovac Biotech and AstraZeneca, Sinopharm is the third company to have its vaccine approved by Indonesia, which is seeking to inoculate 181.5 million people by January 2022.It has suffered one of the worst Covid-19 outbreaks in Asia, with 1.66 million infections and more than…

Read the original article at South China Morning Post